Search Results - Zuniga, Edison S.

Refine Results
  1. 1

    The future for early-stage tuberculosis drug discovery by Zuniga, Edison S, Early, Julie, Parish, Tanya

    Published in Future microbiology (01-02-2015)
    “…There is an urgent need for new and better drugs to treat tuberculosis due to lengthy and complex treatment regimens and a rising problem of drug resistance…”
    Get full text
    Journal Article
  2. 2

    Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents by Kesicki, Edward A, Bailey, Mai A, Ovechkina, Yulia, Early, Julie V, Alling, Torey, Bowman, Julie, Zuniga, Edison S, Dalai, Suryakanta, Kumar, Naresh, Masquelin, Thierry, Hipskind, Philip A, Odingo, Joshua O, Parish, Tanya

    Published in PloS one (12-05-2016)
    “…The 2-aminothiazole series has anti-bacterial activity against the important global pathogen Mycobacterium tuberculosis. We explored the nature of the activity…”
    Get full text
    Journal Article
  3. 3

    Identification of Enolase as the Target of 2-Aminothiazoles in Mycobacterium tuberculosis by Wescott, Heather H, Zuniga, Edison S, Bajpai, Anumita, Trujillo, Carolina, Ehrt, Sabine, Schnappinger, Dirk, Roberts, David M, Parish, Tanya

    Published in Frontiers in microbiology (26-10-2018)
    “…Tuberculosis is a massive global burden and is increasingly resistant to first- and second-line drugs. There is an acute need for new anti-mycobacterial drugs…”
    Get full text
    Journal Article
  4. 4

    Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24 by Botchkina, Galina I, Zuniga, Edison S, Rowehl, Rebecca H, Park, Rosa, Bhalla, Rahuldev, Bialkowska, Agnieszka B, Johnson, Francis, Golub, Lorne M, Zhang, Yu, Ojima, Iwao, Shroyer, Kenneth R

    Published in PloS one (24-09-2013)
    “…Prostate cancer is the second leading cause of cancer death among men. Multiple evidence suggests that a population of tumor-initiating, or cancer stem cells…”
    Get full text
    Journal Article
  5. 5

    The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents by Zuniga, Edison S., Korkegian, Aaron, Mullen, Steven, Hembre, Erik J., Ornstein, Paul L., Cortez, Guillermo, Biswas, Kallolmay, Kumar, Naresh, Cramer, Jeffrey, Masquelin, Thierry, Hipskind, Philip A., Odingo, Joshua, Parish, Tanya

    Published in Bioorganic & medicinal chemistry (01-08-2017)
    “…[Display omitted] We identified a di-substituted triazolopyrimidine with anti-tubercular activity against Mycobacterium tuberculosis. Three segments of the…”
    Get full text
    Journal Article
  6. 6

    New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells by Botchkina, Galina I, Zuniga, Edison S, Das, Manisha, Wang, Yuan, Wang, Hichao, Zhu, Shu, Savitt, Anne G, Rowehl, Rebecca A, Leyfman, Yan, Ju, Jingfang, Shroyer, Kenneth, Ojima, Iwao

    Published in Molecular cancer (14-07-2010)
    “…Growing evidence suggests that the majority of tumors are organized hierarchically, comprising a population of tumor-initiating, or cancer stem cells (CSCs)…”
    Get full text
    Journal Article
  7. 7

    Activation of 2,4-Diaminoquinazoline in Mycobacterium tuberculosis by Rv3161c, a Putative Dioxygenase by Melief, Eduard, Bonnett, Shilah A, Zuniga, Edison S, Parish, Tanya

    Published in Antimicrobial agents and chemotherapy (01-01-2019)
    “…The diaminoquinazoline series has good potency against Resistant isolates have mutations in Rv3161c, a putative dioxygenase. We carried out metabolite analysis…”
    Get full text
    Journal Article
  8. 8

    Design, Synthesis, and Biological Evaluation of Theranostic Vitamin–Linker–Taxoid Conjugates by Vineberg, Jacob G, Wang, Tao, Zuniga, Edison S, Ojima, Iwao

    Published in Journal of medicinal chemistry (12-03-2015)
    “…Novel tumor-targeting theranostic conjugates 1 and 2, bearing either a fluorine-labeled prosthetic as a potential 18F-PET radiotracer (1) or a fluorescence…”
    Get full text
    Journal Article
  9. 9

    Design, Synthesis, and Biological Evaluations of Tumor-Targeting Dual-Warhead Conjugates for a Taxoid–Camptothecin Combination Chemotherapy by Vineberg, Jacob G, Zuniga, Edison S, Kamath, Anushree, Chen, Ying-Jen, Seitz, Joshua D, Ojima, Iwao

    Published in Journal of medicinal chemistry (10-07-2014)
    “…Novel tumor-targeting dual-warhead conjugates, 2 (DW-1) and 3 (DW-2), which consist of a next-generation taxoid, 1 (SB-T-1214), and camptothecin as two…”
    Get full text
    Journal Article
  10. 10

    Fluorine-containing taxoid anticancer agents and their tumor-targeted drug delivery by Seitz, Joshua, Vineberg, Jacob G., Zuniga, Edison S., Ojima, Iwao

    Published in Journal of fluorine chemistry (01-08-2013)
    “…This account presents our recent progress, in perspective, on the strategic incorporation of fluorine(s) for the development of taxoid-based tumor-targeted…”
    Get full text
    Journal Article
  11. 11

    Tumor-targeting drug delivery of new-generation taxoids by Ojima, Iwao, Zuniga, Edison S, Berger, William T, Seitz, Joshua D

    Published in Future medicinal chemistry (01-01-2012)
    “…A long-standing problem of conventional cancer chemotherapy is the lack of tumor specificity. Tumor-targeting drug-delivery systems have been explored to…”
    Get more information
    Journal Article
  12. 12

    Targeted and armed oncolytic adenovirus via chemoselective modification by Banerjee, Partha S., Zuniga, Edison S., Ojima, Iwao, Carrico, Isaac S.

    Published in Bioorganic & medicinal chemistry letters (01-09-2011)
    “…Oncolytic adenoviruses (Ads) are an emerging alternative therapy for cancer; however, clinical trial have not yet demonstrated sufficient efficacy. When…”
    Get full text
    Journal Article
  13. 13

    Design, synthesis and biological evaluation of new-generation taxoid-based tumor-targeting by Zuniga, Edison S

    Published 01-01-2012
    “…Over the past decades, chemotherapy has transitioned to an age of "targeted therapy." The development of Gleevec (Novartis) and Tarceva (Genentech and OSI…”
    Get full text
    Dissertation
  14. 14
  15. 15
  16. 16

    Superovulation strategies for 6 commonly used mouse strains by Luo, Charlie, Zuniga, Juliana, Edison, Earnessa, Palla, Shana, Dong, Wenli, Parker-Thornburg, Jan

    “…We examined different weight ranges and hormone dosages to determine superovulation protocols for 6 mouse strains commonly used in genetic engineering:…”
    Get full text
    Journal Article
  17. 17

    Psychometric Properties of the Recovery Experiences Questionnaire in Peruvian Teachers of Regular Basic Education by Carranza Esteban, Renzo Felipe, Mamani-Benito, Oscar, Zúñiga, Dámaris Quinteros, Turpo Chaparro, Josué Edison, Romero, Abel Apaza, Murillo, Walter

    Published in Frontiers in education (Lausanne) (26-07-2022)
    “…The objective of this study was to analyze the psychometric properties of the recovery experiences questionnaire in Peruvian teachers of regular basic…”
    Get full text
    Journal Article
  18. 18

    Exploitation and potential use of Phytelephasaequatorialis Spruce as a non-timber forest product by Alfredo Jiménez González, Edison Eduardo Saltos Arteaga, Marcos Pedro Ramos Rodríguez, Cristóbal Gonzalo Cantos Cevallos, Mónica Virginia Tapia Zúñiga

    Published in Revista cubana de ciencias forestales (01-09-2018)
    “…In the Andil and Caña Brava communities, adjacent to the estate of the Southern State University of Manabí located on the Jipijapa-Noboa road, a study was…”
    Get full text
    Journal Article
  19. 19
  20. 20